Rozanolixizumab's EU approval for self-administration methods aims to improve patient autonomy and satisfaction by minimizing clinic visits. The phase 3 MG0020 study confirmed the safety and efficacy ...
Redesigned syringe seamlessly blends innovation and functionality, setting a new standard for precision and ease in the injection experience. RALEIGH, N.C., November 03, 2025--(BUSINESS WIRE)--Merz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback